A partial gastrectomy is a surgical procedure where part of the stomach is removed, often due to stomach cancer, ulcers, or other severe gastric issues. This procedure reduces the size of the stomach, leading to reduced food intake, but it also requires significant dietary changes after surgery.

Wegovy is available through the NHS for patients meeting specific criteria. To qualify, individuals generally need to have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as diabetes or hypertension. Wegovy is a relatively new option and is prescribed under careful medical supervision.

The stomach sleeve diet follows the same principles as the gastric sleeve diet. After the surgery, patients must follow a structured eating plan, starting with liquids and progressing to solid foods over several weeks. The diet focuses on small, high-protein meals to support weight loss and ensure adequate nutrition.

The "Skinny Pen" refers to a weight-loss medication called liraglutide (brand name Saxenda) that is administered through a daily injection. It works by mimicking a hormone that regulates appetite, helping patients feel fuller for longer. This treatment is often used for individuals who struggle with obesity but are not candidates for surgery or who need additional help in managing their weight post-bariatric surgery. The drug is available by prescription and is used in conjunction with diet and exercise.

The cost of a gastric band varies by country and healthcare system. In the UK, it can cost between £5,000 to £8,000 privately, while in the U.S., it ranges from $9,000 to $15,000. Some insurance plans may cover the procedure if it's deemed medically necessary for obesity treatment.

Roux-en-Y bypass is another term for the RNY procedure. This surgery helps patients lose weight by creating a small pouch from the stomach and connecting it directly to the small intestine, bypassing a portion of the digestive tract. The result is a reduced ability to absorb calories and nutrients. Patients who undergo RNY experience rapid weight loss, but it also requires them to make permanent changes to their diet and lifestyle to avoid complications like dumping syndrome, where food moves too quickly from the... +More

The "fat jab," also known as Saxenda or liraglutide, is an injectable weight-loss drug that has been approved for use on the NHS in the UK for individuals struggling with obesity. It is intended for use in conjunction with a reduced-calorie diet and increased physical activity. The medication helps control appetite, leading to weight loss. It is typically prescribed to those with a BMI over 30 or individuals with weight-related health problems.

The cost of gastric sleeve surgery varies depending on the country and clinic. In the UK, private gastric sleeve surgery ranges from £8,000 to £12,000. The procedure is also available on the NHS for eligible patients who meet specific criteria, such as having a BMI over 40.

Weight lost refers to the reduction in body weight that is typically achieved through lifestyle changes, medications, or bariatric surgeries like the RNY or gastric band. Weight loss, particularly significant or rapid weight loss, can have dramatic positive effects on a person's overall health, reducing the risk of heart disease, diabetes, and other obesity-related conditions. Successful weight loss usually requires long-term changes to diet, exercise, and behavior.

Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

A GI malignancy refers to any cancerous growth within the gastrointestinal tract. These cancers are often aggressive and can spread quickly if not detected early. Colon cancer, stomach cancer, and pancreatic cancer are common forms of GI malignancy. Gastroenterologists play a vital role in screening for these cancers through procedures like colonoscopies and endoscopies.

The balloon pill, also known as the gastric balloon, is a non-surgical weight-loss device that is swallowed and then inflated inside the stomach. It takes up space, helping patients feel fuller on less food. The balloon is temporary and is usually left in place for six months before being removed. It is a popular option for people who want a non-invasive weight-loss method without committing to surgery.

A mini gastric bypass is a simpler version of the traditional RNY gastric bypass. It involves creating a small stomach pouch and bypassing a section of the small intestine. This procedure is less invasive and typically quicker to perform, with fewer complications. It offers similar weight-loss results to the traditional bypass but may result in higher rates of bile reflux. It is becoming a popular choice for those looking for effective weight-loss surgery with a shorter recovery time.

The gastric balloon pill is a new, non-invasive weight-loss method where a deflated balloon is swallowed in pill form and then inflated in the stomach. Known as the Allurion Balloon, this method reduces the amount of food the stomach can hold, promoting weight loss without surgery.

Patients typically need a Body Mass Index (BMI) of 35 or higher, with obesity-related health conditions, or a BMI of 40 or more to qualify for gastric sleeve surgery. This surgery, known as Vertical Sleeve Gastrectomy (VSG), involves removing about 80% of the stomach to reduce food intake and is one of the most popular bariatric procedures.